Entries by Tanya Samazan

BPI US West: Digital Manufacturing Takes Hold in Bioprocessing

Bioprocessing International (BPI) US West 2021 kicked off its virtual edition this morning, Monday March 29. An annual event, BPI West encompasses presentation, posters and networking events focused on the latest developments in bioprocessing and cell and gene therapy. A talk this morning, “Integration of Paperless Benchtop Instruments in Clinical Manufacturing,” presented by Simon Barskyi […]

BioProcess International US West to Present Latest Developments in Bioprocessing

The annual BioProcess International US West Conference & Exhibition will be held March 29–30 virtually. The conference consists of six tracks: Cell Line Development & Engineering; Cell Culture; Recovery & Purification; Manufacturing Strategy & Bioprocessing 4.0; Intensified & Continuous Processing; Cell & Gene Therapies; and the 4th Annual BioInnovation Group Technology Session. BioProcess International US […]

Danaher’s SCIEX and Molecular Devices Businesses Debut New Products

It has been a busy beginning of the year for Danaher’s Life Sciences segment. In January, the business reported 2020 revenues of $10.6 billion, representing 47% of the total revenues of science and technology conglomerate Danaher. The Life Sciences unit such as biopharmaceuticals and COVID-19 vaccines. In 2020, the pharmaceutical end-market represented approximately 25% of […]

Biden Administration Backs Science

Early signs from the Biden Administration indicate the Administration is elevating the role of science in its policymaking and actions. President Biden has already promoted the role of science advisor and director of the Office of Science and Technology policy to the level of a Cabinet position. Made up of 25 members, Cabinet members serve […]

SARS-CoV-2 Vaccines: Phase 1 vs. Phase 3

With US regulatory emergency use authorization (EUA) of two vaccines, a major threshold has been crossed in the response to COVID-19. According to the latest information, dated December 16, from the World Health Organization (WHO), more SARS-CoV-2 vaccine candidates are moving closer to completing the clinical trial phase. Twenty percent of the candidates in clinical […]

COVID-19 Pandemic Rattles European Universities’ Finances

This month, the European University Association, a representative of more than 800 European universities, issued a new report, “Public Funding Observatory 2020/2021: Part 1: Financial and economic impact of the COVID-19 crisis on universities in Europe.” The report is based on a survey conducted this summer of 29 national European university associations. The report illustrates […]

Life Science Tool Companies’ IPOs Show Impressive Gains

As the stock market continues its gyrations this year in the face of the unprecedented circumstances of COVID-19 and subsequent macroeconomic downtown, how are life science tool companies’ stocks doing? One way to answer this question is to look at companies that have completed IPOs over the past two years. New to the public market […]

US Business R&D Tops $440 Billion in 2018

Published this month, the National Science Foundation’s (NSF’s) review of US business R&D spending in 2018 indicates the robust contribution of business R&D to the economy and the diversity of industries conducting R&D in the US. It also lays out the importance of both manufacturing and non-manufacturing R&D to innovation. Top Spending Total US businesses’ […]

Sequencing Resources Must Progress to Fight COVID-19

A new consensus report, “Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2: Modernizing Pandemic Response Strategies,” from the National Academy of Sciences offers recommendations to address the SARS-CoV-2 pandemic through the integration of genomic, clinical and epidemiological data. The main focus of the report is how viral sequencing is being utilized to address COVID-19 and the […]

Pall Debuts Filtration Solutions for Biotech Research

As the number of biotech drugs in development grows exponentially, lab protein and cell purification workflows are facing increasing demand. Such workflows include clone selection, cell expansion studies and recombinant protein isolation prior to analysis. Suppliers of filtration and clarification consumables have responded by innovating to accelerate these workflows. Pall, one of the largest suppliers […]